机译:Nilotinib Vs Nilotinib加聚乙二醇化干扰素-α2B诱导和NiLotinib或聚乙二醇干扰素-α2B维持治疗用于新诊断的BCR-ABL加慢性慢性骨髓性白血病患者:虎(CML v) - 学生分析
Univ Klinikum Jena Klin Innere Med 2 Jena Germany;
Univ Med Mannheim Mannheim Germany;
Univ Bern Univ Hosp Inselspital Bern Dept Hematol Bern Switzerland;
Rhein Westfal TH Aachen Univ Hosp Dept Hematol Oncol Hemostaseol &
Stem Cell Transp Aachen;
Philips Univ Marburg Dept Internal Med Hematologgy Oncol &
Immunol Marburg Germany;
Schwarzwald Baar Klinikum Villingen Schwenningen Germany;
Ludwig Maximilians Univ Munchen IBE Munich Germany;
ELN Fdn Weinheim Germany;
Univ Hosp Basel Hematol Basel Switzerland;
Univ Klinikum Erlangen Med Klin 5 Erlangen Germany;
Charite Humboldt Univ Hematol &
Oncol Berlin Germany;
Univ Hosp Leipzig Dept Hematol &
Oncol Leipzig Germany;
Masaryk Univ Fac Med Dept Internal Med Hematol &
Oncol Brno Czech Republic;
Asklepios Klinikum Weissenfels Weissenfels Germany;
Klinikum Chemnitz GmbH Dept Hematol Oncol &
Stem Cell Transplantat Chemnitz Germany;
Univ Hosp Ulm Dept Internal Med 3 Ulm Germany;
Ludwig Maximilians Univ Munchen IBE Munich Germany;
Univ Klinikum Jena Abt Hamatol &
Internist Onkol Klin Innere Med 2 Jena Germany;
Univ Klinikum Jena Klin Innere Med 2 Jena Germany;
Ludwig Maximilians Univ Munchen IBE Munich Germany;
机译:Nilotinib Vs Nilotinib加聚乙二醇化干扰素-α2B诱导和NiLotinib或聚乙二醇干扰素-α2B维持治疗用于新诊断的BCR-ABL加慢性慢性骨髓性白血病患者:虎(CML v) - 学生分析
机译:Nilotinib与在慢性相的新诊断的慢性骨髓白血病患者中降低了BCR-ABL突变的发病率Vs伊马替尼。
机译:Nilotinib和Dasatinib疗法在新诊断患者慢性骨髓白血病慢性期患者中的临床结果比较:回顾性分析
机译:胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
机译:与伊马替尼相比尼洛替尼与新诊断为慢性粒细胞白血病的慢性期患者的BCR-ABL突变发生率降低有关